Translational Oncogenomics

Submit a Paper

Call for Papers

The Editor in Chief, Dr. Joan T. Garrett, University of Cincinnati College of Pharmacy, welcomes new manuscripts for peer review on the following topics:

  • Novel genetic, epigenetic and molecular pathway information related to clinical cancer
  • Papers with a translational connection to human cancer from basic science to ethical considerations related to the application of oncogenomic discoveries for diagnostic and prognostic purposes in clinical trials and for anti-cancer drug development
  • An important objective is to contribute information published in this forum to comprehensive internationally-accessible genomic databases in order to foster the identification of molecular targets for the therapy of specific cancers
  • More detailed topics can be found in the journal's Aims & Scope page

Translational Oncogenomics is indexed in PubMed Central (PMC), Scopus, and selected EBSCO, Elsevier, & Gale databases.

Open Special Collections

We are also accepting submissions for the following Special Collections. If any of these are the right fit for your research, we would be happy to receive your paper for peer review. Please enter the Promo Code listed next to each collection below during Step 2 of the submission process to indicate your interest in publishing in this Special Collection.

  • Status of cancer DNA sequencing in the clinic; Promo Code to submit: TOG-6a
  • Pharmacodynamic biomarkers of response and resistance; Promo Code to submit: TOG-9

All papers accepted into these Special Collections will benefit from a reduced Article Processing Charge (APC) of $750 (£500 GBP), discounted from the full rate for a limited time.

Become a Guest Editor for a Special Collection

We are interested in publishing Special Collections on various topics. Peruse the topics, or suggest your own, by submitting a Guest Editor proposal here

Further information on the role can be found in the Lead Guest Editor Guide

Published Special Collections

Benefits of Publishing

The journal offers significant benefits to authors including:

  • International, PubMed-listed, open access journal
  • All articles made immediately freely available on PubMed Central
  • Indexed in Scopus
  • Fast, rigorous peer review
  • Open access format, driving high visibility and global exposure
  • Prompt online publication
  • Article metrics service to allow each author to monitor re-use of published articles

Manuscripts submitted to the journal are subject to double-blind peer review by a minimum of two to three suitably qualified reviewers. All editorial decisions are the responsibility of Editor-in-Chief, Deputy Editor-in-Chief, or an Associate Editor. Each stage of the editorial and production process is monitored to prevent delays to the authors, who are regularly informed of changes in their paper's status. Editorial contributors, journal staff, and external contractors who contribute to editorial and production processes are qualified, experienced professionals chosen for their ability to efficiently contribute towards high-quality published papers. Article processing charges are communicated to authors prior to and during manuscript submission. There are no additional fees based on use of color, figure or word-count.

Further Information

  • Efficient Processing: 4 Weeks Average to First Editorial Decision
  • Fair & Independent Expert Peer Review
  • High Visibility & Extensive Database Coverage
Services for Authors

Quick Links

New article and journal news notification services